What are the major opportunities in the Short Bowel Syndrome market? What are the strategies for the Short Bowel Syndrome market?

For detailed insights on the major opportunities and strategies in the Short Bowel Syndrome market, Read More

How does the Short Bowel Syndrome market relate to the overall economy and other similar markets?

For detailed insights on Short Bowel Syndrome's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Short Bowel Syndrome market growth? SWOT analysis of the Short Bowel Syndrome market.

For detailed insights on the key dynamics influencing the Short Bowel Syndrome market growth and SWOT analysis of the Short Bowel Syndrome industry, Read More

Global Short Bowel Syndrome Market Report 2025

Item added to cart!

Published : December 2025

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Short Bowel Syndrome Global Market Report 2025

Name: Short Bowel Syndrome Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Glucagon-Like Peptide (GLP-,, Growth Hormone, Glutamine), By Diagnosis (Physical Exam, Blood Tests, Fecal Fat Tests, Imaging Procedures, Other Diagnosis), By Treatment (Nutritional Therapy, Medications, Surgery, Transplant), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Other Distribution Channels) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Short Bowel Syndrome Market Overview

• Short Bowel Syndrome market size has reached to $2.69 billion in 2024

• Expected to grow to $5.29 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%

• Growth Driver: Rising Prevalence Of Gastrointestinal Diseases Fueling The Growth Of The Market Due To Increasing Surgical Interventions And Nutrient Malabsorption

• Market Trend: Advancements In GLP-2 Analog Therapies For Short Bowel Syndrome And Intestinal Failure

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Short Bowel Syndrome Market?

Short bowel syndrome (SBS) is a malabsorption disorder caused by the loss or dysfunction of a significant portion of the small intestine, leading to impaired nutrient and fluid absorption. It often results in diarrhea, dehydration, electrolyte imbalances, and malnutrition. The severity of symptoms depends on the remaining intestinal length and its ability to adapt. SBS can significantly impact overall health, requiring careful dietary and medical management.

The main types in short bowel syndrome are glucagon-like peptide (GLP-2), Growth Hormone, and glutamine. Glucagon-Like Peptide-2 (GLP-2) is an intestinal hormone that plays a crucial role in enhancing nutrient absorption, promoting intestinal growth, and reducing gut inflammation, making it a key target for therapies in conditions like Short Bowel Syndrome. These are diagnosed by physical exam, blood tests, fecal fat tests, imaging procedures, and others, and given treatment of nutritional therapy, medications, surgery, and transplant, which are distributed by various channels such as hospital pharmacies, specialty pharmacies, and others.

Short Bowel Syndrome Market Size and growth rate 2025 to 2029: Graph

What Is The Short Bowel Syndrome Market Size 2025 And Growth Rate?

What Is The Short Bowel Syndrome Market Growth Forecast?

The short bowel syndrome market size is expected to see rapid growth in the next few years. It will grow to $5.29 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to the rising prevalence of short bowel syndrome (SBS), growing adoption of parenteral and enteral nutrition therapy, expanding clinical research and drug development, increasing healthcare expenditure, and rising awareness and early diagnosis of SBS. Major trends in the forecast period include advancements in intestinal rehabilitation therapies, development of small intestine transplantation techniques, adoption of telemedicine for SBS management, technological advancements in enteral feeding devices, and integration of artificial intelligence in SBS treatment planning.

The forecast of 14.4% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. patient access by inflating prices of parenteral nutrition solutions and glucagon-like peptide-2 (GLP-2) therapies developed in Sweden and Ireland, resulting in treatment gaps and higher gastroenterology care expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Short Bowel Syndrome Market Segmented?

1) By Type: Glucagon-Like Peptide (GLP-2), Growth Hormone, Glutamine

2) By Diagnosis: Physical Exam, Blood Tests, Fecal Fat Tests, Imaging Procedures, Other Diagnosis

3) By Treatment: Nutritional Therapy, Medications, Surgery, Transplant

4) By Distribution Channel: Hospital Pharmacies, Specialty Pharmacies, Other Distribution Channels

Subsegments:

1) By Glucagon-Like Peptide (GLP-2): Teduglutide, Other GLP-2 Analogues

2) By Growth Hormone: Somatropin, Other Growth Hormone Therapies

3) By Glutamine: Oral Glutamine, Intravenous Glutamine

What Is Driving The Short Bowel Syndrome Market? Rising Prevalence Of Gastrointestinal Diseases Fueling The Growth Of The Market Due To Increasing Surgical Interventions And Nutrient Malabsorption

The increasing prevalence of gastrointestinal diseases is expected to propel the growth of the short bowel syndrome market going forward. Gastrointestinal diseases refer to a broad range of disorders affecting the digestive tract, including conditions impacting the stomach, intestines, liver, and pancreas, often leading to impaired digestion and nutrient absorption. The growing prevalence of gastrointestinal diseases is largely driven by unhealthy dietary habits that disrupt gut health and promote inflammation. Gastrointestinal diseases can contribute to the development of short bowel syndrome by necessitating surgical removal of damaged intestinal segments, leading to reduced absorptive capacity. For instance, in September 2023, according to the Inflammatory Bowel Disease (IBD) Clinical and Research Centre, a Canada-based organization that aims to improve the lives of patients with Crohn's disease and ulcerative colitis, with a prevalence of 825 per 100,000 in 2023, over 320,000 people in Canada have inflammatory bowel disease (IBD), and as the prevalence is expected to increase by 2.44% annually, 1.1% of the population, or 470,000 Canadians, is projected to be living with IBD by 2035. Therefore, the increasing prevalence of gastrointestinal diseases is driving the growth of the short bowel syndrome industry.

Who Are The Major Players In The Global Short Bowel Syndrome Market?

Major companies operating in the short bowel syndrome market are Nestlé SA, Pfizer Inc, Johnson & Johnson, Sanofi SA, Nutrinia, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Zealand Pharma, Baxter International Inc., Alnylam Pharmaceuticals, OPKO Health Inc, Ironwood Pharmaceuticals Inc., Hanmi Pharm Co. Ltd, Ardelyx Inc, Emmaus Life Sciences Inc, Jaguar Health, 9 Meters Biopharma Inc., OxThera Inc. , Adocia SAS, EnteraBio Ltd, GLyPharma Therapeutic Inc.

What Are The Key Trends Of The Global Short Bowel Syndrome Market? Advancements In GLP-2 Analog Therapies For Short Bowel Syndrome And Intestinal Failure

Major companies operating in the short bowel syndrome market are focusing on developing innovative advancements in medical science, such as treatments for intestinal failure, to provide an advanced therapeutic option that improves treatment outcomes for patients with gastrointestinal disorders. Intestinal failure is a critical condition where the small intestine cannot absorb enough nutrients, fluids, and electrolytes to maintain proper hydration and nutrition. For instance, in May 2024, Ironwood Pharmaceuticals, Inc., a US-based healthcare company, unveiled new data from studies evaluating apraglutide in adults with short bowel syndrome and intestinal failure (SBS-IF). As a next-generation GLP-2 analog, apraglutide demonstrated potential to enhance intestinal absorption and reduce reliance on parenteral support. The findings underscore the drug’s efficacy, safety, and long-term benefits, reflecting Ironwood’s commitment to developing innovative therapies for gastrointestinal disorders.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Short Bowel Syndrome Market? Takeda Pharmaceutical Partners With Inspire To Address Unmet Needs Of Short Bowel Syndrome Patients

In May 2024, Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical company, collaborated with Inspire (Patient Community Platform) to improve the overall understanding of patient experiences and challenges in managing complex gastrointestinal conditions. This collaboration aims to leverage real-world patient insights through multidisciplinary research to identify gaps in care, enhance patient support, and drive innovation in treatment approaches for short bowel syndrome. Inspire (Patient Community Platform) is a US-based online health and wellness community that connects patient engagement and real-world data platforms.

What Is The Regional Outlook For The Global Short Bowel Syndrome Market?

North America was the largest region in the short bowel syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Short Bowel Syndrome Market?

The short bowel syndrome market consists of revenues earned by entities by providing services such as medical care, diagnostic testing, nutritional support, and ongoing patient management. The market value includes the value of related goods sold by the service provider or included within the service offering. The short bowel syndrome market also includes sales of oral rehydration solutions, antidiarrheal medications, proton pump inhibitors, antimotility agents, bile acid binders, antimicrobials, and specialized enteral nutrition formulas. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Short Bowel Syndrome Industry?

The short bowel syndrome market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the short bowel syndrome industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Short Bowel Syndrome Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$3.08 billion
Revenue Forecast In 2034	$5.29 billion
Growth Rate	CAGR of 14.4% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The short bowel syndrome market covered in this report is segmented – 1) By Type: Glucagon-Like Peptide (GLP- 2), Growth Hormone, Glutamine 2) By Diagnosis: Physical Exam, Blood Tests, Fecal Fat Tests, Imaging Procedures, Other Diagnosis 3) By Treatment: Nutritional Therapy, Medications, Surgery, Transplant 4) By Distribution Channel: Hospital Pharmacies, Specialty Pharmacies, Other Distribution Channels Subsegments: 1) By Glucagon-Like Peptide (GLP- 2): Teduglutide, Other GLP-2 Analogues 2) By Growth Hormone: Somatropin, Other Growth Hormone Therapies 3) By Glutamine: Oral Glutamine, Intravenous Glutamine
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Request for Sample
Customization Scope	Explore Purchase Options
Pricing And Purchase Options

1. Executive Summary

2. Short Bowel Syndrome Market Characteristics

3. Short Bowel Syndrome Market Trends And Strategies

4. Short Bowel Syndrome Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Short Bowel Syndrome Growth Analysis And Strategic Analysis Framework

5.1. Global Short Bowel Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Short Bowel Syndrome Market Growth Rate Analysis

5.4. Global Short Bowel Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Short Bowel Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Short Bowel Syndrome Total Addressable Market (TAM)

6. Short Bowel Syndrome Market Segmentation

6.1. Global Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Glucagon-Like Peptide (GLP-2)

Growth Hormone

Glutamine

6.2. Global Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Physical Exam

Blood Tests

Fecal Fat Tests

Imaging Procedures

Other Diagnosis

6.3. Global Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Nutritional Therapy

Medications

Surgery

Transplant

6.4. Global Short Bowel Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Specialty Pharmacies

Other Distribution Channels

6.5. Global Short Bowel Syndrome Market, Sub-Segmentation Of (Glucagon-Like Peptide) GLP-2, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Teduglutide

Other GLP-2 Analogues

6.6. Global Short Bowel Syndrome Market, Sub-Segmentation Of Growth Hormone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Somatropin

Other Growth Hormone Therapies

6.7. Global Short Bowel Syndrome Market, Sub-Segmentation Of Glutamine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Glutamine

Intravenous Glutamine

7. Short Bowel Syndrome Market Regional And Country Analysis

7.1. Global Short Bowel Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Short Bowel Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Short Bowel Syndrome Market

8.1. Asia-Pacific Short Bowel Syndrome Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Short Bowel Syndrome Market

9.1. China Short Bowel Syndrome Market Overview

9.2. China Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Short Bowel Syndrome Market

10.1. India Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Short Bowel Syndrome Market

11.1. Japan Short Bowel Syndrome Market Overview

11.2. Japan Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Short Bowel Syndrome Market

12.1. Australia Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Short Bowel Syndrome Market

13.1. Indonesia Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Short Bowel Syndrome Market

14.1. South Korea Short Bowel Syndrome Market Overview

14.2. South Korea Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Short Bowel Syndrome Market

15.1. Western Europe Short Bowel Syndrome Market Overview

15.2. Western Europe Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Short Bowel Syndrome Market

16.1. UK Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Short Bowel Syndrome Market

17.1. Germany Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Short Bowel Syndrome Market

18.1. France Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Short Bowel Syndrome Market

19.1. Italy Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Short Bowel Syndrome Market

20.1. Spain Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Short Bowel Syndrome Market

21.1. Eastern Europe Short Bowel Syndrome Market Overview

21.2. Eastern Europe Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Short Bowel Syndrome Market

22.1. Russia Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Short Bowel Syndrome Market

23.1. North America Short Bowel Syndrome Market Overview

23.2. North America Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Short Bowel Syndrome Market

24.1. USA Short Bowel Syndrome Market Overview

24.2. USA Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Short Bowel Syndrome Market

25.1. Canada Short Bowel Syndrome Market Overview

25.2. Canada Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Short Bowel Syndrome Market

26.1. South America Short Bowel Syndrome Market Overview

26.2. South America Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Short Bowel Syndrome Market

27.1. Brazil Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Short Bowel Syndrome Market

28.1. Middle East Short Bowel Syndrome Market Overview

28.2. Middle East Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Short Bowel Syndrome Market

29.1. Africa Short Bowel Syndrome Market Overview

29.2. Africa Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Short Bowel Syndrome Market Competitive Landscape And Company Profiles

30.1. Short Bowel Syndrome Market Competitive Landscape

30.2. Short Bowel Syndrome Market Company Profiles

30.2.1. Nestlé SA Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Nutrinia Overview, Products and Services, Strategy and Financial Analysis

31. Short Bowel Syndrome Market Other Major And Innovative Companies

31.1. GlaxoSmithKline plc

31.2. Takeda Pharmaceutical Company Limited

31.3. Zealand Pharma

31.4. Baxter International Inc.

31.5. Alnylam Pharmaceuticals

31.6. OPKO Health Inc

31.7. Ironwood Pharmaceuticals Inc.

31.8. Hanmi Pharm Co. Ltd

31.9. Ardelyx Inc

31.10. Emmaus Life Sciences Inc

31.11. Jaguar Health

31.12. 9 Meters Biopharma Inc.

31.13. OxThera Inc.

31.14. Adocia SAS

31.15. EnteraBio Ltd

32. Global Short Bowel Syndrome Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Short Bowel Syndrome Market

34. Recent Developments In The Short Bowel Syndrome Market

35. Short Bowel Syndrome Market High Potential Countries, Segments and Strategies

35.1 Short Bowel Syndrome Market In 2029 - Countries Offering Most New Opportunities

35.2 Short Bowel Syndrome Market In 2029 - Segments Offering Most New Opportunities

35.3 Short Bowel Syndrome Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Short Bowel Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Short Bowel Syndrome Market, Sub-Segmentation Of (Glucagon-Like Peptide) GLP-2, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Short Bowel Syndrome Market, Sub-Segmentation Of Growth Hormone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Short Bowel Syndrome Market, Sub-Segmentation Of Glutamine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Short Bowel Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Short Bowel Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Nestlé SA Financial Performance

Table 79: Pfizer Inc Financial Performance

Table 80: Johnson & Johnson Financial Performance

Table 81: Sanofi SA Financial Performance

Table 82: Nutrinia Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Short Bowel Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Short Bowel Syndrome Market, Sub-Segmentation Of (Glucagon-Like Peptide) GLP-2, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Short Bowel Syndrome Market, Sub-Segmentation Of Growth Hormone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Short Bowel Syndrome Market, Sub-Segmentation Of Glutamine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Short Bowel Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Short Bowel Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Nestlé SA Financial Performance

Figure 79: Pfizer Inc Financial Performance

Figure 80: Johnson & Johnson Financial Performance

Figure 81: Sanofi SA Financial Performance

Figure 82: Nutrinia Financial Performance

Next-Gen Primary Immunodeficiency Disorders : Market Forecast, Transformation, and Long-Term Trajectories

Proteus Syndrome Growth Trajectory: Key Forecasts and Strategic Insights

Prothrombin Complex Concentrate Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prothrombin Complex Concentrate Market Landscape: Advanced Radiation Therapy Systems Enhancing Precision And Patient Outcomes

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Bowel Management Systems Global Market Report 2025 – By Product (Colostomy Bags, Irrigation Systems, Nerve Modulation Devices, Other Products), By Patient Type (Adults, Pediatric), By End-User (Hospitals, Ambulatory Cent...

Inflammatory Bowel Disease Treatment Global Market Report 2025 – By Drug Class (Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes), By Type (Crohn's Disea...

Ulcerative Colitis Global Market Report 2025 – By Drug Type (Anti-Inflammatory Drugs, Anti-TNF Biologics, Immunosuppressant, Calcineurin Inhibitors, Other Drug Types), By Disease Type (Ulcerative Proctitis, Proctosigmoid...

Intestinal Pseudo-Obstruction Treatment Global Market Report 2025 – By Drug Class (Antibiotics, Antidepressants, Antidiarrheals), By Treatment (Medication, Surgery, Diet, Decompression, Other Treatments), By Route Of Adm...

Constipation Laxative Global Market Report 2025 – By Drug Type (Bulk-Forming Laxatives, Stimulant Laxatives, Osmotic Laxative, Other Drugs), By Route Of Administration (Oral, Rectal), By Distribution Channel (Hospital Ph...

Intestinal Pseudo-Obstruction Treatment Global Market Report 2025 – By Drug Class (Antibiotics, Antidepressants, Antidiarrheals), By Treatment (Medication, Surgery, Diet, Decompression, Other Treatments), By Route Of Adm...

Constipation Treatment Global Market Report 2025 – By Therapeutic Types (Laxatives, Chloride Channel Activators, Peripherally Acting Mu-Opioid Receptor Antagonists, GC-C (Guanylate Cyclase-C) Agonists, Other Therapeutics...

Frequently Asked Questions

What is the definition of the Short Bowel Syndrome market?

How will the Short Bowel Syndrome market drivers and restraints affect the market dynamics? What forces will shape the Short Bowel Syndrome industry going forward?

The market major growth driver - Rising Prevalence Of Gastrointestinal Diseases Fueling The Growth Of The Market Due To Increasing Surgical Interventions And Nutrient Malabsorption. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Short Bowel Syndrome market?

The short bowel syndrome market size has grown rapidly in recent years. It will grow from $2.69 billion in 2024 to $3.08 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to increasing prevalence of gastrointestinal disorders, rising healthcare expenditure and insurance coverage, improvements in post-surgical management of SBS, an increase in prevalence of Crohn’s disease and other GI disorders, and improved parenteral nutrition formulations and administration techniques. The short bowel syndrome market size is expected to see rapid growth in the next few years. It will grow to " $5.29 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to the rising prevalence of short bowel syndrome (SBS), growing adoption of parenteral and enteral nutrition therapy, expanding clinical research and drug development, increasing healthcare expenditure, and rising awareness and early diagnosis of SBS. Major trends in the forecast period include advancements in intestinal rehabilitation therapies, development of small intestine transplantation techniques, adoption of telemedicine for SBS management, technological advancements in enteral feeding devices, and integration of artificial intelligence in SBS treatment planning. For further insights on this market, request a sample here

How is the Short Bowel Syndrome market segmented?

The short bowel syndromemarket covered in this report is segmented –
1) By Type: Glucagon-Like Peptide (GLP-2); Growth Hormone; Glutamine
2) By Diagnosis: Physical Exam; Blood Tests; Fecal Fat Tests; Imaging Procedures; Other Diagnosis
3) By Treatment: Nutritional Therapy; Medications; Surgery; Transplant
4) By Distribution Channel: Hospital Pharmacies; Specialty Pharmacies; Other Distribution Channels Subsegments:
1) By Glucagon-Like Peptide (GLP-2): Teduglutide; Other GLP-2 Analogues
2) By Growth Hormone: Somatropin; Other Growth Hormone Therapies
3) By Glutamine: Oral Glutamine; Intravenous Glutamine For further insights on this market, request a sample here

Which region has the largest share of the Short Bowel Syndrome market? What are the other regions covered in the report?

North America was the largest region in the short bowel syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the short bowel syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Short Bowel Syndrome market?

What are the key trends in the Short Bowel Syndrome market?

Major trends in this market include Advancements In GLP-2 Analog Therapies For Short Bowel Syndrome And Intestinal Failure. For further insights on this market, request a sample here.